Search results
Is Pfizer Inc. (NYSE:PFE) the Best Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Pfizer Stock: Surging Cancer Rates Will Boost Revenues (NYSE:PFE)
Seeking Alpha· 12 hours agoAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 2 hours agoBiotech stock hit a two-year high in February, but have trended sideways in the months since despite...
Pfizer (NYSE:PFE) Trading 0.3% Higher
ETF DAILY NEWS· 1 day agoPfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.3% during mid-day trading on Tuesday . The company traded as high as $29.73 and last traded at $29.41. 9,834,266 shares ...
Is Pfizer the Best Dividend Stock for You? | The Motley Fool
The Motley Fool· 7 days agoThe pandemic-influenced revenue gusher from which pharmaceutical giant Pfizer (PFE 1.63%) benefitted...
Is Pfizer the Best Dividend Stock for You?
Motley Fool via Yahoo Finance· 7 days agoThe pandemic-influenced revenue gusher from which pharmaceutical giant Pfizer (NYSE: PFE) benefitted a few years ago has trickled down to a small stream....
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 3 hours agoThe vaccine is based on protein technology, differentiating it from Pfizer's and Moderna's messenger...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 8 hours agoUsually, RSV causes coldlike symptoms in most people. But in newborns and older adults it can be...
Why Things Could Get Worse for Pfizer Stock Before They Get Better | The Motley Fool
The Motley Fool· 2 days agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (PFE 0.20%) stock was a hot buy...
Why Things Could Get Worse for Pfizer Stock Before They Get Better
The Motley Fool via AOL· 2 days agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (NYSE: PFE) stock was a hot buy...